MELINDA JENKINS: Open Payments
NPI 1861720294 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 19 payments from 8 companies in 2025. Trend: 2023 $1,534 · 2024 $1,788 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $87 |
| Amgen Inc. | 4 | $70 |
| Philips North America LLC | 2 | $60 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: LifeVest, REPATHA, Ambulatory Monitoring & Diagnostics Undivided, FARXIGA, JARDIANCE, LEQVIO, ONPATTRO, ELIQUIS.
Industry payments across SC — which companies pay providers there.
